KYOTO-SEMICONDUCTOR
26.5.2020 07:02:11 CEST | Business Wire | Press release
In the forty years since the company’s founding, Kyoto Semiconductor Co., Ltd., Tsuneo Takahashi, President and CEO, and headquartered in Fushimi Ward, Kyoto, has led the industry with optical solutions built from world-standard technologies and with Japanese quality and attention to production detail. They have announced the development of a Two-Wavelength Photodiode, the KP-2 Two-tone Photodiode KPMC29, in the industry’s smallest class and capable of being surface-mounted, with silicon and indium-gallium-arsenide photodiodes, with photosensitivity for a wide range of wavelengths, from 400 to 1,700 nm, arrayed along the same light axis.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200525005017/en/
This broadband sensitivity, together with a smaller package that is 1/8 the volume ratio of older Kyoto Semiconductor products, can be used in the healthcare field for applications that include medical biometric monitoring like pulse oximeters as well as wearable activity monitors. Because it is also possible to independently produce photocurrent signals from the silicon and indium-gallium-arsenide photodiodes, measuring the photocurrent ratio will allow for its use as a radiation thermometer that can measure temperatures without direct contact with hot object.
Development Background
Spectroscopic analysis technology, that allows for the identification of objects and their characteristics without needing direct contact with those objects, by reflecting light of those objects and measuring the degrees of transmission and reflection, is increasingly needed in a wide range of fields, including medicine, production, and security. Spectroscopic analysis relies on two factors for successful use in identifying a wide range of objects: a wider range of wavelengths, or colors, for the source wavelengths, and a wider range of sensitivity for those wavelengths with the photodiode end. There is also a need for smaller products, compared to existing corded-lead products, for use with medical equipment or wearable devices that can be worn directly on the human body.
Development was therefore undertaken to meet these product needs.
Product Characteristics
-
A wider range of wavelength sensitivity (400~1,700nm).
To expand the wavelength range, we layered both silicon photodiodes, which are sensitive to shorter wavelengths, and indium-gallium-arsenide photodiodes, which are sensitive to longer wavelengths, along the same light axis. -
A compact surface-mountable package in the industry’s smallest class.
To successfully make this KP-2 two-tone PD smaller, the indium-gallium-arsenide photodiodes were laid down in pits arranged on the base for the silicon photodiodes, which ordinarily allows light to pass through. This allowed for the package height to be as low as possible. (Patents have been filed.)
Compared to earlier products from Kyoto Semiconductor, the volume ratio has been reduced to 1/8.
See the following for more information. (https://www.kyosemi.co.jp/en/lp/kpmc29/ )
Samples will be available from August 31, 2020.
Mass production orders will begin on April 1, 2021.
Kyoto Semiconductor
Kyoto Semiconductor was established in 1980 in Kyoto as a dedicated manufacturer of optical semiconductors. The semiconductors manufactured offer superlative performance and precision, suited for use in optical transmission. They are manufactured end-to-end, including pre- and post-processing, and together with Kyoto Semiconductor’s unique packaging technology, at our location in Japan and made available to customers around the world. Kyoto Semiconductor leads the industry with world-standard technologies for optical device solutions based on Japanese quality and attention to production detail.
Company Website: https://www.kyosemi.co.jp/
View source version on businesswire.com: https://www.businesswire.com/news/home/20200525005017/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
HCL Group and UpLink Launch Fifth Global Aquapreneur Innovation Challenge to Advance Future Water Systems22.4.2026 13:16:00 CEST | Press release
HCL Group, in partnership with UpLink - the early-stage innovation initiative of the World Economic Forum - has launched the fifth global challenge under the Aquapreneur Innovation Initiative, titled Transforming Water Systems. Applications will be open from 22 April to 4 June 2026. The top 10 winners will receive a total financial award of CHF 1.75 million. For details on eligibility and application criteria, visit: UpLink - Transforming Water Systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260421866128/en/ The Aquapreneur Innovation Initiative is a five-year, CHF 15 million collaboration between UpLink, HCL Group, and the World Economic Forum’s Food and Water Initiative, focused on building a global innovation ecosystem for freshwater solutions. Important Dates to Note 22 April to 4 June 2026 Open for submissions July to August 2026 Review and selection process January 2027 Announcement of the winners As water syst
Veristat to Acquire Certara’s Regulatory and Medical Writing Business22.4.2026 13:00:00 CEST | Press release
Strategic acquisition expands and enhances Veristat’s regulatory services to help more clinical trial sponsors develop novel, life-saving therapies across complex disease areas Veristat (the “Company”), a science-first full-service CRO and consultancy that advances complex therapies through the drug development lifecycle to regulatory submission, announced today its intended acquisition of Certara’s Regulatory and Medical Writing business. The team that will join Veristat is known for its white-glove advisory services and deep expertise authoring clinical and non-clinical documents throughout the drug development lifecycle. The acquisition is supported by WindRose Health Investors, LLC, a New York-based healthcare private equity firm, which remains a partner in driving Veristat's growth trajectory and mission. Notably, the acquisition expands Veristat’s regulatory writing and submission capabilities by adding more than 200 industry experts. Combined with the strong track record and mar
BeOne Medicines to Announce First Quarter 2026 Financial Results on May 622.4.2026 12:01:00 CEST | Press release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its first quarter 2026 financial results on Wednesday, May 6, 2026 before the financial markets open. Following the release of the financials, the Company will host a live webcast with management at 8:00 a.m. ET. The live webcast of this event can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com.To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An archived webcast will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capa
Smartstream Research Reveals Five Realities Redefining Buy-Side Reconciliations22.4.2026 10:05:00 CEST | Press release
Key Facts Over 70% of firms still rely primarily on end-of-day reconciliation, while 53% cite timing differences and data mismatches as the leading causes of breaks. 59% of participants identified external data dependencies as the primary risk, while 47% highlighted internal inconsistencies. And 41% struggle with incomplete or insufficiently enriched data. 69% describe their T+1 model as partially adapted and still evolving. Whilst 41% say T+1 has made data quality a critical priority. Smartstream, the trusted data solutions provider for leading global financial institutions and enterprises, today announces new findings from its latest industry research report, Smart Reconciliations: The Buy-Side Perspective, highlighting the structural shifts transforming reconciliation, control, and operational confidence across buy-side firms. Based on insights gathered from a roundtable of senior operations leaders across asset management and investment firms, the report identifies five critical re
‘Concrete in Life 2025/26’ Winners Announced – Spectacular Photographs From Around the World22.4.2026 10:00:00 CEST | Press release
Concrete in Life Photo of the Year from the Philippines wins $10,000 top prize Over 20,000 international entries from professional photographers and smartphone amateurs Concrete is the world’s most used substance after water Powerful and striking images from around the world have been chosen as the winners of the Concrete in Life 2025/26 global photography competition, showcasing the essential role concrete plays in daily life, infrastructure, cities, and design. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422352135/en/ OVERALL WINNER: Pillars Across the Sea by Celbert Palaganas, Cebu City, Philippines Run by the Global Cement and Concrete Association (GCCA), the annual competition received more than 20,000 entries from professional and amateur photographers, as well as smartphone users, spanning every continent. The competition highlights how concrete supports modern life while also offering moments of beauty, creativ
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
